Parasitemia levels rose in anti-IP-10-injected mice after treatment cessation during the second week of infection, resembling parasitic burden observed in CM-resistant mouse strains such as BALB/c [13]. This evidence concerns the gene CXCL10 and parasitic infectious disease.